class=”sc-3778e872-0 cKDKQr”>
Three months have already passed this year. Three months in which stock prices fluctuate back and forth. Overall, the leading Swiss index is up a good three percent so far this year. First, it made a steep upward curve fueled by falling corona restrictions in China. However, fears about interest rates and the economy quickly drove the price down again.
14 out of 20 SMI titles increased. The shares of the cement producer Holcim received the most attention. This is probably because of the band’s solid numbers. Shares of Sonova and Richemont were also in particularly high demand, with Richemont particularly benefiting from openings in China.
| Stocks winning on SMI | Change from 31/12/22 |
| holcim | +22 percent |
| sonova | +21 percent |
| Richemont | +20 percent |
Then, the bank earthquake that started in the USA in mid-March put a lot of pressure on the stock market. Fear of the financial crisis appears to have subsided. However, an expert from Raiffeisen Bank warns that the danger in the banking sector has not yet been averted.
Unsurprisingly, Credit Suisse shares lost over 70 percent at most. By contrast, UBS even gained 9 percent in the first three months of the year.
Demand for papers from Logitech and Roche was much less. Logitech has been experiencing a drop in demand since the end of the corona crisis. Investors were disappointed with this outlook. Roche is still struggling with expired patents for key drugs. The lack of Corona income also slows down the pharmaceutical giant.
| Losing stock in SMI | Change from 31/12/22 |
| Logitech | -9 percent |
| Roche | -10 per cent |
| CreditSuisse | -71 percent |
If you look at the SPI, that is, all shares on the Swiss stock market, the index rose 5.7 percent. However, many stocks are probably almost unknown to the public.
Newron Pharmaceuticals had a rocket start this year: +281 percent. Recently, the biotech company achieved “impressive” results with a drug against schizophrenia. A second biotech company also posted strong earnings (+79 percent) with Addex Therapeutics.
However, Credit Suisse isn’t the only big loser. Talenthouse shares, for example, are down 55 percent since the start of the year. Now turning to tech platforms, the company wants to risk a fresh start with a restructuring.
GAM is also struggling with a 42 percent drop. The asset manager is apparently urgently looking for a buyer.
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
On the same day of the terrorist attack on the Krokus City Hall in Moscow,…
class="sc-cffd1e67-0 iQNQmc">1/4Residents of Tenerife have had enough of noisy and dirty tourists.It's too loud, the…
class="sc-cffd1e67-0 iQNQmc">1/7Packing his things in Munich in the summer: Thomas Tuchel.After just over a year,…
At least seven people have been killed and 57 injured in severe earthquakes in the…
The American space agency NASA would establish a uniform lunar time on behalf of the…
class="sc-cffd1e67-0 iQNQmc">1/8Bode Obwegeser was surprised by the earthquake while he was sleeping. “It was a…